These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 33952315)
1. Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa. Farinre O; Gounder K; Reddy T; Tongo M; Hare J; Chaplin B; Gilmour J; Kanki P; Mann JK; Ndung'u T Retrovirology; 2021 May; 18(1):11. PubMed ID: 33952315 [TBL] [Abstract][Full Text] [Related]
2. Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression. Kiguoya MW; Mann JK; Chopera D; Gounder K; Lee GQ; Hunt PW; Martin JN; Ball TB; Kimani J; Brumme ZL; Brockman MA; Ndung'u T J Virol; 2017 Jul; 91(13):. PubMed ID: 28424286 [TBL] [Abstract][Full Text] [Related]
3. Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon. Ragupathy V; Zhao J; Wood O; Tang S; Lee S; Nyambi P; Hewlett I Virol J; 2011 Apr; 8():185. PubMed ID: 21513545 [TBL] [Abstract][Full Text] [Related]
4. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals. Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907 [TBL] [Abstract][Full Text] [Related]
5. HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1. Miura T; Brockman MA; Brumme ZL; Brumme CJ; Pereyra F; Trocha A; Block BL; Schneidewind A; Allen TM; Heckerman D; Walker BD J Virol; 2009 Jan; 83(1):140-9. PubMed ID: 18971283 [TBL] [Abstract][Full Text] [Related]
6. A novel multiregion hybridization assay reveals high frequency of dual inter-subtype infections among HIV-positive individuals in Cameroon, West Central Africa. Vidal N; Diop H; Montavon C; Butel C; Bosch S; Ngole EM; Touré-Kane C; Mboup S; Delaporte E; Peeters M Infect Genet Evol; 2013 Mar; 14():73-82. PubMed ID: 23232100 [TBL] [Abstract][Full Text] [Related]
7. Increased replication capacity following evolution of PYxE insertion in Gag-p6 is associated with enhanced virulence in HIV-1 subtype C from East Africa. Aralaguppe SG; Winner D; Singh K; Sarafianos SG; Quiñones-Mateu ME; Sönnerborg A; Neogi U J Med Virol; 2017 Jan; 89(1):106-111. PubMed ID: 27328744 [TBL] [Abstract][Full Text] [Related]
8. Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity. Kinloch NN; Lee GQ; Carlson JM; Jin SW; Brumme CJ; Byakwaga H; Muzoora C; Bwana MB; Cobarrubias KD; Hunt PW; Martin JN; Carrington M; Bangsberg DR; Harrigan PR; Brockman MA; Brumme ZL J Virol; 2019 Jan; 93(1):. PubMed ID: 30305354 [TBL] [Abstract][Full Text] [Related]
9. Mother-to-Child HIV Transmission Bottleneck Selects for Consensus Virus with Lower Gag-Protease-Driven Replication Capacity. Naidoo VL; Mann JK; Noble C; Adland E; Carlson JM; Thomas J; Brumme CJ; Thobakgale-Tshabalala CF; Brumme ZL; Brockman MA; Goulder PJR; Ndung'u T J Virol; 2017 Sep; 91(17):. PubMed ID: 28637761 [TBL] [Abstract][Full Text] [Related]
10. Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters. Wright JK; Brumme ZL; Carlson JM; Heckerman D; Kadie CM; Brumme CJ; Wang B; Losina E; Miura T; Chonco F; van der Stok M; Mncube Z; Bishop K; Goulder PJ; Walker BD; Brockman MA; Ndung'u T J Virol; 2010 Oct; 84(20):10820-31. PubMed ID: 20702636 [TBL] [Abstract][Full Text] [Related]
11. Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C. Wright JK; Novitsky V; Brockman MA; Brumme ZL; Brumme CJ; Carlson JM; Heckerman D; Wang B; Losina E; Leshwedi M; van der Stok M; Maphumulo L; Mkhwanazi N; Chonco F; Goulder PJ; Essex M; Walker BD; Ndung'u T J Virol; 2011 Apr; 85(8):3996-4006. PubMed ID: 21289112 [TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G. Konings FA; Burda ST; Urbanski MM; Zhong P; Nadas A; Nyambi PN J Med Virol; 2006 May; 78(5):523-34. PubMed ID: 16555291 [TBL] [Abstract][Full Text] [Related]
14. Near full-length genome analysis of HIV type 1 CRF02.AG subtype C and CRF02.AG subtype G recombinants. Janssens W; Salminen MO; Laukkanen T; Heyndrickx L; van der Auwera ; Colebunders R; McCutchan FE; van der Groen G AIDS Res Hum Retroviruses; 2000 Aug; 16(12):1183-9. PubMed ID: 10954895 [TBL] [Abstract][Full Text] [Related]
15. Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacity. Wright JK; Naidoo VL; Brumme ZL; Prince JL; Claiborne DT; Goulder PJ; Brockman MA; Hunter E; Ndung'u T J Virol; 2012 Mar; 86(6):3193-9. PubMed ID: 22238317 [TBL] [Abstract][Full Text] [Related]
16. A restriction enzyme based cloning method to assess the in vitro replication capacity of HIV-1 subtype C Gag-MJ4 chimeric viruses. Claiborne DT; Prince JL; Hunter E J Vis Exp; 2014 Aug; (90):. PubMed ID: 25225725 [TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa. Imamichi H; Koita O; Dabitao D; Dao S; Ibrah M; Sogoba D; Dewar RL; Berg SC; Jiang MK; Parta M; Washington JA; Polis MA; Lane HC; Tounkara A AIDS Res Hum Retroviruses; 2009 Jan; 25(1):45-55. PubMed ID: 19182920 [TBL] [Abstract][Full Text] [Related]
18. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. Gao F; Robertson DL; Morrison SG; Hui H; Craig S; Decker J; Fultz PN; Girard M; Shaw GM; Hahn BH; Sharp PM J Virol; 1996 Oct; 70(10):7013-29. PubMed ID: 8794346 [TBL] [Abstract][Full Text] [Related]
19. The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness. Njai HF; Gali Y; Vanham G; Clybergh C; Jennes W; Vidal N; Butel C; Mpoudi-Ngolle E; Peeters M; Ariën KK Retrovirology; 2006 Jul; 3():40. PubMed ID: 16817969 [TBL] [Abstract][Full Text] [Related]